Willow Biosciences Inc. (TSX:WLLW)

Market Cap	724.23K
Revenue (ttm)	4.66M
Net Income (ttm)	-6.19M
Shares Out	144.85M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,000
Average Volume	694,630
Open	0.0050
Previous Close	0.0050
Day's Range	0.0050 - 0.0100
52-Week Range	0.0050 - 0.1450
Beta	0.94
RSI	30.64
Earnings Date	Mar 26, 2025

About Willow Biosciences

Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation; and a multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2019
• Employees: 19
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: WLLW

Financial Performance

In 2024, Willow Biosciences's revenue was 4.66 million, an increase of 297.78% compared to the previous year's 1.17 million. Losses were -6.19 million, -52.50% less than in 2023.